STICCHI, ALESSANDRO
 Distribuzione geografica
Continente #
AS - Asia 2.802
NA - Nord America 2.178
EU - Europa 732
SA - Sud America 584
Continente sconosciuto - Info sul continente non disponibili 160
AF - Africa 117
OC - Oceania 4
Totale 6.577
Nazione #
US - Stati Uniti d'America 2.042
CN - Cina 1.009
SG - Singapore 636
BR - Brasile 446
IT - Italia 340
HK - Hong Kong 301
VN - Vietnam 222
KR - Corea 128
IN - India 93
BD - Bangladesh 83
DE - Germania 73
GB - Regno Unito 69
JP - Giappone 63
FR - Francia 58
IQ - Iraq 58
CA - Canada 42
AR - Argentina 40
FI - Finlandia 39
SA - Arabia Saudita 33
ZA - Sudafrica 33
MX - Messico 30
VE - Venezuela 30
NL - Olanda 26
RU - Federazione Russa 26
TR - Turchia 23
AT - Austria 22
CO - Colombia 20
ID - Indonesia 19
PK - Pakistan 19
ES - Italia 17
EG - Egitto 16
UZ - Uzbekistan 16
EC - Ecuador 15
JO - Giordania 14
SE - Svezia 14
AE - Emirati Arabi Uniti 13
JM - Giamaica 13
MA - Marocco 13
NP - Nepal 12
TN - Tunisia 11
TT - Trinidad e Tobago 11
UA - Ucraina 11
KE - Kenya 10
PL - Polonia 10
UY - Uruguay 9
CL - Cile 8
IL - Israele 8
PY - Paraguay 8
HN - Honduras 6
AZ - Azerbaigian 5
CR - Costa Rica 5
KW - Kuwait 5
OM - Oman 5
PS - Palestinian Territory 5
AU - Australia 4
BB - Barbados 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
IE - Irlanda 4
KG - Kirghizistan 4
KZ - Kazakistan 4
NG - Nigeria 4
NI - Nicaragua 4
PE - Perù 4
BE - Belgio 3
BW - Botswana 3
ET - Etiopia 3
GA - Gabon 3
GE - Georgia 3
MK - Macedonia 3
MY - Malesia 3
PA - Panama 3
PH - Filippine 3
PT - Portogallo 3
AO - Angola 2
BF - Burkina Faso 2
BS - Bahamas 2
BY - Bielorussia 2
GR - Grecia 2
LB - Libano 2
MN - Mongolia 2
QA - Qatar 2
RO - Romania 2
RS - Serbia 2
SN - Senegal 2
SR - Suriname 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BZ - Belize 1
CD - Congo 1
CG - Congo 1
CI - Costa d'Avorio 1
Totale 6.393
Città #
Shanghai 470
Santa Clara 415
Singapore 370
Hong Kong 283
San Jose 248
Hefei 184
Ashburn 138
Seoul 128
Los Angeles 122
Boardman 106
Dallas 78
Buffalo 75
Ho Chi Minh City 74
Council Bluffs 71
Tokyo 52
Beijing 51
Hanoi 50
São Paulo 39
Rome 34
Milan 33
Pisa 33
Dhaka 28
Helsinki 27
Lauterbourg 25
Florence 23
Baghdad 19
Nuremberg 19
Cascina 18
Haiphong 18
Munich 18
New York 15
Tashkent 15
Amman 14
Atlanta 14
Chicago 14
Johannesburg 14
Redondo Beach 14
Rio de Janeiro 14
Frankfurt am Main 13
Denver 12
Jeddah 12
Mexico City 12
Erbil 11
Massa e Cozzile 11
Naples 11
Belo Horizonte 10
Düsseldorf 10
Bologna 9
Da Nang 9
Fuzhou 9
Istanbul 9
Nairobi 9
Turin 9
Vienna 9
Brasília 8
Cape Town 8
Columbus 8
Hải Dương 8
Lappeenranta 8
London 8
Montevideo 8
New Delhi 8
Riyadh 8
San Francisco 8
Cairo 7
Kingston 7
Osaka 7
Tunis 7
Baltimore 6
Basra 6
Biên Hòa 6
Curitiba 6
Delhi 6
Genoa 6
Karachi 6
Manchester 6
Montreal 6
Palermo 6
Santo André 6
Surat 6
Baku 5
Campinas 5
Chennai 5
Dammam 5
Figino 5
Fortaleza 5
Houston 5
Kathmandu 5
Orem 5
Phoenix 5
Recife 5
Salt Lake City 5
Santiago 5
Stockholm 5
Amsterdam 4
Barquisimeto 4
Bexley 4
Bogotá 4
Bridgetown 4
Buenos Aires 4
Totale 3.802
Nome #
Illusory Coronary Obstruction After BASILICA: In IVUS We Trust! 257
Drug-eluting balloon in the treatment of in-stent restenosis and diffuse coronary artery disease: Real-world experience from our registry 225
Hemodynamic and Metabolic-Inflammatory Phenotyping Across the Cardiac Index Spectrum in Moderate and Severe Tricuspid Regurgitation: Prognostic Implications 218
Clinical outcomes following bioresorbable scaffold implantation in small vessels 181
Global Prevalence of Mitral Regurgitation: A Systematic Review and Meta-Analysis of Population-Based Studies 142
Transthoracic and transoesophageal echocardiography for tricuspid transcatheter edge-to-edge repair: a step-by-step protocol 125
Impact of Pulmonary Hypertension on Outcomes After Transcatheter Tricuspid Valve Edge-to-Edge Repair 121
Atrial Secondary Tricuspid Regurgitation: Insights Into the EuroTR Registry 115
Long Stent Implantation on the Left Anterior Descending Coronary Artery at a Follow-Up of More Than Five Years 113
Transcatheter Aortic Valve Implantation to Treat Degenerated Aortic, Mitral and Tricuspid Bioprosthesis 110
Gender-Specific Outcomes in TAVI with Self-Expandable Valves: Insights from a Large Real-World Registry 109
The Incidence and Impact of In-Hospital Bleeding in Patients with Acute Coronary Syndrome during the COVID-19 Pandemic 108
Comprehensive insights into peripheral artery disease: an overview from the working groups of pathogenesis of atherosclerosis and thrombosis of the Italian Society of Cardiology 108
Optical coherence tomography 107
Impact of design characteristics among studies comparing coronary computed tomography angiography to noninvasive functional testing in chronic coronary syndromes 104
Diabetes and mortality in patients with COVID-19: Are we missing the link? 103
Correlation Between Voltage and Impedance Mapping in Patients with Atrial Fibrillation 102
Transcatheter Tricuspid Valve Replacement: Current Options and Future Perspectives 102
Chiusura dell’auricola sinistra: selezione del paziente 101
Coronary Artery Dissection in Drug-Coated Balloon Angioplasty: Incidence, Predictors, and Clinical Outcomes 101
Symptoms-to-emergency-call timing delay in acute coronary syndrome before and during COVID-19: independent predictors and their impact on mortality 99
Retrograde Retrieval of a Novel Large Mitral Clip After Embolization Into the Left Ventricle 97
Usefulness of Adding Pre-procedural Glycemia to the Mehran Score to Enhance Its Ability to Predict Contrast-induced Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention Development and Validation of a Predictive Model 95
Tricuspid Transcatheter Orthotopic and Heterotopic Replacement Screening F.A.I.L.: First Attempt In Learning! 94
Heterotopic Transcatheter Tricuspid Valve Implantation: A Useful Bailout Strategy After Failed Transcatheter Tricuspid Valve Repair? 92
Transseptal Balloon-Assisted Translocation of the Mitral Anterior Leaflet (BATMAN) in Mitral Valve-in-Ring Implantation 91
Clinical Outcomes After Implantation of Overlapping Bioresorbable Scaffolds vs New Generation Everolimus Eluting Stents [Resultados clínicos tras el implante de armazones bioabsorbibles solapados en comparación con stents liberadores de everolimus de nueva generación] 82
Comparison of Mid-Term Prognosis in Intermediate-to-Low-Risk Contemporary Population with Guidelines-Oriented Age Cutoff 80
Mitral regurgitation evolution after transcatheter tricuspid valve interventions-a sub-analysis of the TriValve registry 79
Percutaneous Tricuspid Valve Repair 78
Drug-Coated Balloon Angioplasty for De Novo Lesions on the Left Anterior Descending Artery 74
Use of sirolimus-coated balloon in de novo coronary lesions; long-term clinical outcomes from a multi-center real-world population 73
Mortality benefit with different antithrombotic therapies in patients with stable vascular disease: From pathophysiology to the clinical impact in the real world. The COMPASS study [Beneficio di mortalità delle terapie antitrombotiche in pazienti con malattia vascolare stabile: Dalla fisiopatologia all'impatto clinico e al suo ruolo nel mondo reale. focus sullo studio COMPASS] 70
Prediction of Mortality and Heart Failure Hospitalization After Transcatheter Tricuspid Valve Interventions: Validation of TRISCORE 68
Clinical and procedural outcomes of percutaneous coronary intervention for de novo lesions involving the ostial left circumflex coronary artery 66
Malnutrition and outcomes in patients with tricuspid regurgitation undergoing transcatheter tricuspid valve repair 65
Comparison of early clinical outcomes between ABSORB bioresorbable vascular scaffold and everolimus-eluting stent implantation in a real-world population 63
Combined Caval Valved Stent Implantation and Leaflet Approximation for Treatment of Torrential Tricuspid Regurgitation 62
Coronary and total thoracic calcium scores predict mortality and provides pathophysiologic insights in COVID-19 patients 59
Letter: Completeness or complexity? A nuanced reflection on multivessel revascularisation 58
Stress-induced cardiomyopathy related to SARS-CoV-2 58
Clinical outcomes of suboptimal stent deployment as assessed by optical coherence tomography: long-term results of the CLI-OPCI registry 57
Computed tomography analysis of coronary ostia location following valve-in-valve transcatheter aortic valve replacement with the ACURATE neo valve: Implications for coronary access 56
Adoption of a new automated optical coherence tomography software to obtain a lipid plaque spread-out plot 54
Procedural outcomes of patients with calcified lesions treated with bioresorbable vascular scaffolds 53
Coronary occlusion after valve-in-valve transcatheter aortic valve replacement with bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction (BASILICA) in a patient with narrow sinotubular junction 53
Coronary access following ACURATE neo implantation for transcatheter aortic valve-in-valve implantation: Ex vivo analysis in patient-specific anatomies 51
Expanding our horizons for the use of transcatheter self-expanding valves: what does the future hold? 50
Prediction of type 4a myocardial infarction with the angiography-derived hemodynamic (ADDED) index 50
Vascular approaches and its potential implications in transcatheter aortic valve implantation 48
Functional and Echocardiographic Improvement After Transcatheter Repair for Tricuspid Regurgitation: A Systematic Review and Pooled Analysis 47
Dual antiplatelet therapy in coronary artery disease: from the past to the future prospective 47
Platelet reactivity and clinical outcomes following percutaneous coronary intervention in complex higher-risk patients 47
First generation versus new generation drug-eluting stents for the treatment of ostial/midshaft lesions in unprotected left main coronary artery: The Milan and New-Tokyo (MITO) registry 47
Acute Right Ventricular Reshaping After TriClip in Ebstein's-Like Anomaly Assessed by Multimodality Imaging 46
Rupture of a vulnerable plaque in a hazy angiographic culprit lesion during acute coronary syndrome 45
Safety and Efficacy of Single Versus Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion 44
Expansion in calcific lesions and overall clinical outcomes following bioresorbable scaffold implantation optimized with intravascular ultrasound 43
Impact of Strut Width in Periprocedural Myocardial Infarction: A Propensity-Matched Comparison Between Bioresorbable Scaffolds and the First-Generation Sirolimus-Eluting Stent 43
Treatment of drug-eluting stent restenosis: Comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study 42
Comparison of abluminal biodegradable polymer biolimus-eluting stents and durable polymer everolimus-eluting stents in the treatment of coronary bifurcations 42
Clinical outcomes following target lesion revascularization for bioresorbable scaffold failure 42
Subclinical atrial fibrillation: When to give NAO? 42
Short-term outcomes following "full-plastic jacket" everolimus-eluting bioresorbable scaffold implantation 41
Thrombotic Versus Bleeding Risk After Transcatheter Aortic Valve Replacement: JACC Review Topic of the Week 41
Comparison of first- and second-generation drug-eluting stents in saphenous vein grafts used as aorto-coronary conduits 41
Comparison of results of transcatheter aortic valve implantation in patients with severely stenotic bicuspid versus tricuspid or nonbicuspid valves 40
A Comparison between First-Generation and Second-Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Propensity-Matched Single-Center Experience 40
Contributors to survival benefit of dual versus single antithrombotic therapy in chronic coronary syndrome: Survival benefit of dual antithrombotic therapy in CCS 39
Biolimus-eluting stent for de-novo coronary artery disease in patients with diabetes mellitus: The BESTFRIENDS multicentre registry 39
Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19 39
Trans-subclavian versus transapical access for transcatheter aortic valve implantation: A multicenter study 39
Impact of Chronic Kidney Disease and Platelet Reactivity on Clinical Outcomes Following Percutaneous Coronary Intervention 39
Outcomes After Transcatheter Aortic Valve Replacement in Bicuspid Versus Tricuspid Anatomy: A Systematic Review and Meta-Analysis 39
Extended follow-up following "full-metal jacket" percutaneous coronary interventions with drug-eluting stents 38
The "hybrid" strategy for complete myocardial revascularization in the frail elderly patient [La strategia "ibrida" per il conseguimento di una rivascolarizzazione miocardica completa nel paziente anziano fragile] 38
First- versus second-generation drug-eluting stents for the treatment of coronary bifurcations 38
Clinical outcomes following bioresorbable scaffold implantation for bifurcation lesions: Overall outcomes and comparison between provisional and planned double stenting strategy 37
Reply: Transcatheter Repair for Tricuspid Regurgitation: Ready or Not? 37
Thrombus aspiration in primary percutaneous coronary intervention: Still a valid option with improved technique in selected patients! 37
The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease 37
Renal denervation in a patient with two renal accessory arteries: A case report 37
Comparison of incidence and predictors of left bundle branch block after transcatheter aortic valve implantation using the corevalve versus the edwards valve 37
Surgical treatment of paravalvular leak: Long-term results in a single-center experience (up to 14 years) 36
Meta-Regression to Identify Patients Deriving the Greatest Benefit from Dual Antiplatelet Therapy after Stroke or Transient Ischemic Attack Without Thrombolytic or Thrombectomy Treatment 36
The role of everolimus-eluting and resolute zotarolimus-eluting stents in the treatment of coronary bifurcations 36
Conventional surgery and transcatheter closure via surgical transapical approach for paravalvular leak repair in high-risk patients: Results from a single-centre experience 36
Acute Tricuspid Valve Remodelling After MitraClip Deployment: Rationale for a Dual-Staged Procedure 35
Long-term outcomes after transcatheter aortic valve implantation from a single high-volume center (The Milan Experience) 35
Iatrogenic aorta-coronary dissection: Case report and systematic review 35
Causes and timing of death during long-term follow-up after transcatheter aortic valve replacement 34
Transradial versus transfemoral ancillary approach in complex structural, coronary, and peripheral interventions. Results from the multicenter ancillary registry: A study of the Italian Radial Club 34
Learning From Failure at the CUTTING-EDGE of Transcatheter Mitral Valve Therapies 33
Transcatheter Mitral Valve Replacement for Mitral Valve-in-Valve, Valve-in-Ring, and Valve-in-MAC Using Balloon-Expandable Transcatheter Heart Valves 33
Newly available and recent advances in drug-eluting stents 32
Patient selection, procedural planning and interventional guidance for transcatheter aortic valve intervention 31
Fractional flow reserve (FFR) as a guide to treat coronary artery disease 29
Immediate and follow-up outcomes of drug-coated balloon angioplasty in de novo long lesions on large coronary arteries 25
Totale 6.577
Categoria #
all - tutte 15.448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.448


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024108 0 0 0 0 0 0 74 0 0 9 2 23
2024/20252.873 55 79 175 41 245 172 502 38 121 161 209 1.075
2025/20263.078 286 374 309 330 361 139 458 161 166 243 91 160
2026/2027518 120 398 0 0 0 0 0 0 0 0 0 0
Totale 6.577